The identifiable virtual patient model: Comparison of simulation and clinical closed-loop study results

Journal of Diabetes Science and Technology

Volumn 6, Issue 2, 2012, Pages 371-379

  Kanderian, Sami S ^a   Weinzimer, Stuart A ^b   Steil, Garry M ^c  

^a Yale University ^*

^b YALE UNIVERSITY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Algorithm; Artificial pancreas; Automated; Closed loop; Diabetes; Insulin delivery; Mathematical model

Indexed keywords

CARBOHYDRATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ADULT DISEASE; ALGORITHM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IDENTIFIABLE VIRTUAL PATIENT MODEL; INSULIN BLOOD LEVEL; MATHEMATICAL MODEL; MORNING DOSAGE; SIMULATION; ADOLESCENT; ANALYSIS OF VARIANCE; BIOLOGICAL MODEL; BLOOD; CARBOHYDRATE DIET; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPUTER SIMULATION; DIET RESTRICTION; DRUG EFFECT; EATING; EVALUATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; METABOLISM; MIDDLE AGED; POSTPRANDIAL STATE; REPRODUCIBILITY; TEACHING; TIME;

ADOLESCENT; ADULT; ALGORITHMS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; COMPUTER SIMULATION; DIABETES MELLITUS, TYPE 1; DIETARY CARBOHYDRATES; EATING; FASTING; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MIDDLE AGED; MODELS, BIOLOGICAL; PATIENT SIMULATION; POSTPRANDIAL PERIOD; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84865120977     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600223     Document Type: Article

References (28)

1. Fischer U, Salzsieder E, Jutzi E, Albrecht G, Freyse EJ. Modelling the glucose-insulin system as a basis for the artificial beta cell. Biomed Biochim Acta. 1984;43(5):597-605. (Pubitemid 14000638)
2. Wilinska ME, Chassin LJ, Acerini CL, Allen JM, Dunger DB, Hovorka R. Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes. J Diabetes Sci Technol. 2010;4(1):132-44.
3. Kovatchev BP, Breton M, Dalla Man C, Cobelli C. In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009;3(1):44-55.
4. Stocker D, Kanderian S, Cortina GJ, Nitzan T, Plummer J, Steil GM, Mastrototaro J, inventors; Medtronic MiniMed, Inc., assignee. Virtual patient software system for educating and treating individuals with diabetes. United States patent application US 2006/0272652. 2006 December 7.
5. Steil GM, Clark B, Kanderian S, Rebrin K. Modeling insulin action for development of a closed-loop artificial pancreas. Diabetes Technol. Ther. 2005 2;7(1):94-108.
6. Kanderian S, Weinzimer S, Voskanyan G, Steil GM. Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes. J Diabetes Sci Technol. 2009;3(5):1047-57.
7. Rebrin K, Fischer U, von Woedtke T, Abel P, Brunstein E. Automated feedback control of subcutaneous glucose concentration in diabetic dogs. Diabetologia. 1989;32(8):573-6. (Pubitemid 19215438)
8. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB. Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet. 2010;375(9716):743-51.
9. Elleri D, Allen JM, Nodale M, Wilinska ME, Mangat JS, Larsen AM, Acerini CL, Dunger DB, Hovorka R. Automated overnight closed-loop glucose control in young children with type 1 diabetes. Diabetes Technol Ther. 2011;13(4):419-24.
10. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol. 2009;3(5):1031-8.
11. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006;55(12):3344-50. (Pubitemid 44923591)
12. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008;31(5):934-9.
13. Steil GM, Palerm CC, Kurtz N, Voskanyan G, Roy A, Paz S, Kandeel FR. The efect of insulin feedback on closed loop glucose control. J Clin Endocrinol Metab. 2011;96(5):1402-8.
14. Kanderian S, Steil GM, inventors; Medtronic MiniMed, Inc., assignee. Apparatus and method for controlling insulin infusion with state variable feedback. United States patent US 7,806,886. 2010 Oct 5.
15. Augstein P, Vogt L, Kohnert KD, Heinke P, Salzsieder E. Translation of personalized decision support into routine diabetes care. J Diabetes Sci Technol. 2010;4(6):1532-9.
16. Salzsieder E, Vogt L, Kohnert KD, Heinke P, Augstein P. Model-based decision support in diabetes care. Comput Methods Programs Biomed. 2011;102(2):206-18.
17. Insel PA, Kramer KJ, Sherwin RS, Liljenquist JE, Tobin JD, Andres R, Berman M. Modeling the insulin-glucose system in man. Fed Proc. 1974;33(7):1865-8.
18. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236(6):E667-77. (Pubitemid 9220487)
19. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 1981;68(6):1456-67. (Pubitemid 12194400)
20. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal- model approach. Diabetes. 1989;38(12):1512-27. (Pubitemid 20006675)
21. Bergman RN. Minimal model: perspective from 2005. Horm Res. 2005;64(Suppl 3):8-15. (Pubitemid 43163307)
22. Steil GM, Reifman J. Mathematical modeling research to support the development of automated insulin-delivery systems. J Diabetes Sci Technol. 2009;3(2):388-95.
23. Steil GM, Hipszer B, Reifman J. Update on mathematical modeling research to support the development of automated insulin delivery systems. J Diabetes Sci Technol. 2010;4(3):759-69.
24. Rebrin K, Sheppard NF, Steil GM. Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor ofset. J Diabetes Sci Technol. 2010;4(5):1087-98.
25. Kovatchev BP, Breton MD, Cobelli C, Dalla Man C, inventors; University of Virginia Patent Foundation, assignee. Method, system and computer simulation environment for testing of monitoring and control strategies in diabetes. United States patent application US 2010/0179768. 2010 July 15.
26. Cobelli C, Dalla Man C, Sparacino G, Magni L, De Nicolao G, Kovatchev BP. Diabetes: models, signals, and control. IEEE Rev Biomed Eng. 2009;2:54-96.
27. Salzsieder E, Vogt L, Kohnert KD, Heinke P, Augstein P. Model-based decision support in diabetes care. Comput Methods Programs Biomed. 2011;102(2):206-18.
28. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010;4;2(27):27ra27.